Do analysts prefer AVNS or TMCI?

Treace Medical Concepts has a consensus target price of $4.97, suggesting a potential upside of 24.25%. Given Treace Medical Concepts' stronger consensus rating and higher probable upside, analysts plainly believe Treace Medical Concepts is more favorable than Avanos Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Treace Medical Concepts 2 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.86

Does the media favor AVNS or TMCI?

In the previous week, Treace Medical Concepts had 4 more articles in the media than Avanos Medical. MarketBeat recorded 5 mentions for Treace Medical Concepts and 1 mentions for Avanos Medical. Treace Medical Concepts' average media sentiment score of 0.27 beat Avanos Medical's score of 0.00 indicating that Treace Medical Concepts is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Treace Medical Concepts 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor AORT or TMCI?

In the previous week, Artivion had 2 more articles in the media than Treace Medical Concepts. MarketBeat recorded 7 mentions for Artivion and 5 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.27 beat Artivion's score of 0.20 indicating that Treace Medical Concepts is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Artivion 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Treace Medical Concepts 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer TNDM or TMCI?

In the previous week, Treace Medical Concepts had 2 more articles in the media than Tandem Diabetes Care. MarketBeat recorded 5 mentions for Treace Medical Concepts and 3 mentions for Tandem Diabetes Care. Tandem Diabetes Care's average media sentiment score of 1.87 beat Treace Medical Concepts' score of 0.27 indicating that Tandem Diabetes Care is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tandem Diabetes Care 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Treace Medical Concepts 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer TMCI or DRTS?

In the previous week, Alpha Tau Medical had 2 more articles in the media than Treace Medical Concepts. MarketBeat recorded 7 mentions for Alpha Tau Medical and 5 mentions for Treace Medical Concepts. Alpha Tau Medical's average media sentiment score of 0.56 beat Treace Medical Concepts' score of 0.27 indicating that Alpha Tau Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Alpha Tau Medical 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer TMCI or BVS?

In the previous week, Treace Medical Concepts had 2 more articles in the media than Bioventus. MarketBeat recorded 5 mentions for Treace Medical Concepts and 3 mentions for Bioventus. Bioventus' average media sentiment score of 1.22 beat Treace Medical Concepts' score of 0.27 indicating that Bioventus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Bioventus 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Treace Medical Concepts (TMCI) Competitors

$4.00 -0.05 (-1.23%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$4.00 0.00 (0.00%)

As of 07/24/2026 04:47 PM Eastern

Compare

TMCI vs. AVNS, AORT, TNDM, DRTS, and BVS

Should you buy Treace Medical Concepts stock or one of its competitors? MarketBeat compares Treace Medical Concepts with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Treace Medical Concepts include Avanos Medical (AVNS), Artivion (AORT), Tandem Diabetes Care (TNDM), Alpha Tau Medical (DRTS), and Bioventus (BVS). These companies are all part of the "medical equipment" industry.

How does Treace Medical Concepts compare to Avanos Medical?

Avanos Medical (NYSE:AVNS) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

Avanos Medical has a beta of 1.57, indicating that its share price is 57% more volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.37, indicating that its share price is 37% more volatile than the broader market.

Treace Medical Concepts has lower revenue, but higher earnings than Avanos Medical. Avanos Medical is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avanos Medical	$701.20M	1.67	-$72.90M	-$1.61	N/A
Treace Medical Concepts	$207.32M	1.25	-$59M	-$0.97	N/A

Avanos Medical has a net margin of -10.39% compared to Treace Medical Concepts' net margin of -29.44%. Avanos Medical's return on equity of 5.39% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avanos Medical	-10.39%	5.39%	3.97%
Treace Medical Concepts	-29.44%	-67.04%	-30.28%

In the previous week, Treace Medical Concepts had 4 more articles in the media than Avanos Medical. MarketBeat recorded 5 mentions for Treace Medical Concepts and 1 mentions for Avanos Medical. Treace Medical Concepts' average media sentiment score of 0.27 beat Avanos Medical's score of 0.00 indicating that Treace Medical Concepts is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avanos Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Treace Medical Concepts	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

95.2% of Avanos Medical shares are held by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are held by institutional investors. 2.3% of Avanos Medical shares are held by insiders. Comparatively, 23.4% of Treace Medical Concepts shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Treace Medical Concepts has a consensus target price of $4.97, suggesting a potential upside of 24.25%. Given Treace Medical Concepts' stronger consensus rating and higher probable upside, analysts plainly believe Treace Medical Concepts is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avanos Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

Summary

Treace Medical Concepts beats Avanos Medical on 9 of the 16 factors compared between the two stocks.

How does Treace Medical Concepts compare to Artivion?

Artivion (NYSE:AORT) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment.

Artivion has a net margin of 2.55% compared to Treace Medical Concepts' net margin of -29.44%. Artivion's return on equity of 7.15% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Artivion	2.55%	7.15%	3.63%
Treace Medical Concepts	-29.44%	-67.04%	-30.28%

In the previous week, Artivion had 2 more articles in the media than Treace Medical Concepts. MarketBeat recorded 7 mentions for Artivion and 5 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.27 beat Artivion's score of 0.20 indicating that Treace Medical Concepts is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Artivion	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Treace Medical Concepts	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Artivion has higher revenue and earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Artivion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Artivion	$458.69M	2.68	$9.77M	$0.24	105.50
Treace Medical Concepts	$207.32M	1.25	-$59M	-$0.97	N/A

Artivion has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.37, indicating that its stock price is 37% more volatile than the broader market.

86.4% of Artivion shares are held by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are held by institutional investors. 6.3% of Artivion shares are held by company insiders. Comparatively, 23.4% of Treace Medical Concepts shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Artivion presently has a consensus price target of $44.17, suggesting a potential upside of 74.44%. Treace Medical Concepts has a consensus price target of $4.97, suggesting a potential upside of 24.25%. Given Artivion's stronger consensus rating and higher possible upside, equities research analysts clearly believe Artivion is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Artivion	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.75
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

Summary

Artivion beats Treace Medical Concepts on 13 of the 16 factors compared between the two stocks.

How does Treace Medical Concepts compare to Tandem Diabetes Care?

Tandem Diabetes Care (NASDAQ:TNDM) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, media sentiment, analyst recommendations and risk.

84.1% of Treace Medical Concepts shares are held by institutional investors. 2.1% of Tandem Diabetes Care shares are held by insiders. Comparatively, 23.4% of Treace Medical Concepts shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Tandem Diabetes Care has a beta of 1.58, meaning that its stock price is 58% more volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.37, meaning that its stock price is 37% more volatile than the broader market.

Tandem Diabetes Care has a net margin of -9.20% compared to Treace Medical Concepts' net margin of -29.44%. Tandem Diabetes Care's return on equity of -53.88% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tandem Diabetes Care	-9.20%	-53.88%	-7.88%
Treace Medical Concepts	-29.44%	-67.04%	-30.28%

Tandem Diabetes Care presently has a consensus price target of $28.93, suggesting a potential upside of 68.95%. Treace Medical Concepts has a consensus price target of $4.97, suggesting a potential upside of 24.25%. Given Tandem Diabetes Care's stronger consensus rating and higher probable upside, equities analysts plainly believe Tandem Diabetes Care is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tandem Diabetes Care	1 Sell rating(s)	11 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.45
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

In the previous week, Treace Medical Concepts had 2 more articles in the media than Tandem Diabetes Care. MarketBeat recorded 5 mentions for Treace Medical Concepts and 3 mentions for Tandem Diabetes Care. Tandem Diabetes Care's average media sentiment score of 1.87 beat Treace Medical Concepts' score of 0.27 indicating that Tandem Diabetes Care is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tandem Diabetes Care	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Treace Medical Concepts	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Treace Medical Concepts has lower revenue, but higher earnings than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tandem Diabetes Care	$1.03B	1.14	-$204.71M	-$1.40	N/A
Treace Medical Concepts	$207.32M	1.25	-$59M	-$0.97	N/A

Summary

Tandem Diabetes Care beats Treace Medical Concepts on 10 of the 17 factors compared between the two stocks.

How does Treace Medical Concepts compare to Alpha Tau Medical?

Treace Medical Concepts (NASDAQ:TMCI) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

Alpha Tau Medical has a net margin of 0.00% compared to Treace Medical Concepts' net margin of -29.44%. Treace Medical Concepts' return on equity of -67.04% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treace Medical Concepts	-29.44%	-67.04%	-30.28%
Alpha Tau Medical	N/A	-73.23%	-52.90%

In the previous week, Alpha Tau Medical had 2 more articles in the media than Treace Medical Concepts. MarketBeat recorded 7 mentions for Alpha Tau Medical and 5 mentions for Treace Medical Concepts. Alpha Tau Medical's average media sentiment score of 0.56 beat Treace Medical Concepts' score of 0.27 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Treace Medical Concepts	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alpha Tau Medical	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Alpha Tau Medical has lower revenue, but higher earnings than Treace Medical Concepts. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treace Medical Concepts	$207.32M	1.25	-$59M	-$0.97	N/A
Alpha Tau Medical	N/A	N/A	-$42.63M	-$0.67	N/A

84.1% of Treace Medical Concepts shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 23.4% of Treace Medical Concepts shares are owned by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Treace Medical Concepts presently has a consensus target price of $4.97, suggesting a potential upside of 24.25%. Alpha Tau Medical has a consensus target price of $12.60, suggesting a potential upside of 0.80%. Given Treace Medical Concepts' higher possible upside, equities analysts plainly believe Treace Medical Concepts is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86
Alpha Tau Medical	2 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.38

Treace Medical Concepts has a beta of 1.37, indicating that its share price is 37% more volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.17, indicating that its share price is 17% more volatile than the broader market.

Summary

Alpha Tau Medical beats Treace Medical Concepts on 8 of the 15 factors compared between the two stocks.

How does Treace Medical Concepts compare to Bioventus?

Treace Medical Concepts (NASDAQ:TMCI) and Bioventus (NASDAQ:BVS) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.

Treace Medical Concepts has a beta of 1.37, suggesting that its share price is 37% more volatile than the broader market. Comparatively, Bioventus has a beta of 0.65, suggesting that its share price is 35% less volatile than the broader market.

Bioventus has higher revenue and earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Bioventus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treace Medical Concepts	$207.32M	1.25	-$59M	-$0.97	N/A
Bioventus	$568.09M	1.74	$22.73M	$0.41	28.78

In the previous week, Treace Medical Concepts had 2 more articles in the media than Bioventus. MarketBeat recorded 5 mentions for Treace Medical Concepts and 3 mentions for Bioventus. Bioventus' average media sentiment score of 1.22 beat Treace Medical Concepts' score of 0.27 indicating that Bioventus is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Treace Medical Concepts	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Bioventus	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Bioventus has a net margin of 4.94% compared to Treace Medical Concepts' net margin of -29.44%. Bioventus' return on equity of 29.97% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treace Medical Concepts	-29.44%	-67.04%	-30.28%
Bioventus	4.94%	29.97%	9.52%

84.1% of Treace Medical Concepts shares are owned by institutional investors. Comparatively, 62.9% of Bioventus shares are owned by institutional investors. 23.4% of Treace Medical Concepts shares are owned by insiders. Comparatively, 33.5% of Bioventus shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Treace Medical Concepts currently has a consensus price target of $4.97, indicating a potential upside of 24.25%. Bioventus has a consensus price target of $14.75, indicating a potential upside of 25.00%. Given Bioventus' stronger consensus rating and higher possible upside, analysts plainly believe Bioventus is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86
Bioventus	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.00

Summary

Bioventus beats Treace Medical Concepts on 14 of the 17 factors compared between the two stocks.

Get Treace Medical Concepts News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TMCI vs. The Competition

Export

Metric	Treace Medical Concepts	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$259.49M	$7.28B	$6.86B	$12.25B
Dividend Yield	N/A	1.33%	2.67%	9.79%
P/E Ratio	-4.12	48.63	27.14	23.64
Price / Sales	1.25	96.85	517.01	89.03
Price / Cash	N/A	25.71	50.54	59.64
Price / Book	2.92	6.73	10.28	6.07
Net Income	-$59M	$162.27M	$3.60B	$331.99M
7 Day Performance	-6.98%	-5.05%	-1.27%	-0.63%
1 Month Performance	-10.11%	-5.86%	-0.37%	-2.00%
1 Year Performance	-29.82%	-2.88%	18.30%	13.62%

Treace Medical Concepts Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TMCI Treace Medical Concepts	3.1412 of 5 stars	$4.00 -1.2%	$4.97 +24.3%	-30.9%	$259.49M	$207.32M	N/A	250	News Coverage Positive News
AVNS Avanos Medical	0.4895 of 5 stars	$24.96 +0.1%	N/A	+110.1%	$1.17B	$701.20M	N/A	2,287
AORT Artivion	3.8441 of 5 stars	$23.16 -3.6%	$44.17 +90.7%	-18.5%	$1.17B	$441.33M	96.52	1,800	News Coverage Analyst Forecast
TNDM Tandem Diabetes Care	2.7543 of 5 stars	$15.54 -4.4%	$29.13 +87.4%	+10.9%	$1.11B	$1.01B	N/A	2,500	Positive News
DRTS Alpha Tau Medical	1.602 of 5 stars	$12.34 +1.3%	$12.60 +2.1%	+313.9%	$1.10B	N/A	N/A	80	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TMCI) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Treace Medical Concepts (TMCI) Competitors

TMCI vs. AVNS, AORT, TNDM, DRTS, and BVS

How does Treace Medical Concepts compare to Avanos Medical?

Summary

How does Treace Medical Concepts compare to Artivion?

Summary

How does Treace Medical Concepts compare to Tandem Diabetes Care?

Summary

How does Treace Medical Concepts compare to Alpha Tau Medical?

Summary

How does Treace Medical Concepts compare to Bioventus?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMCI vs. The Competition

Treace Medical Concepts Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Treace Medical Concepts (TMCI) Competitors

TMCI vs. AVNS, AORT, TNDM, DRTS, and BVS

How does Treace Medical Concepts compare to Avanos Medical?

Which has more risk and volatility, AVNS or TMCI?

Which has stronger earnings & valuation, AVNS or TMCI?

Is AVNS or TMCI more profitable?

Does the media favor AVNS or TMCI?

Do institutionals and insiders hold more shares of AVNS or TMCI?

Do analysts prefer AVNS or TMCI?

Summary

How does Treace Medical Concepts compare to Artivion?

Is AORT or TMCI more profitable?

Does the media favor AORT or TMCI?

Which has better valuation & earnings, AORT or TMCI?

Which has more volatility and risk, AORT or TMCI?

Do insiders and institutionals hold more shares of AORT or TMCI?

Do analysts prefer AORT or TMCI?

Summary

How does Treace Medical Concepts compare to Tandem Diabetes Care?

Do institutionals and insiders hold more shares of TNDM or TMCI?

Which has more volatility & risk, TNDM or TMCI?

Is TNDM or TMCI more profitable?

Do analysts prefer TNDM or TMCI?

Does the media prefer TNDM or TMCI?

Which has better earnings & valuation, TNDM or TMCI?

Summary

How does Treace Medical Concepts compare to Alpha Tau Medical?

Is TMCI or DRTS more profitable?

Does the media prefer TMCI or DRTS?

Which has better valuation and earnings, TMCI or DRTS?

Do institutionals & insiders hold more shares of TMCI or DRTS?

Do analysts recommend TMCI or DRTS?

Which has more volatility & risk, TMCI or DRTS?

Summary

How does Treace Medical Concepts compare to Bioventus?

Which has more volatility and risk, TMCI or BVS?

Which has preferable earnings and valuation, TMCI or BVS?

Does the media prefer TMCI or BVS?

Is TMCI or BVS more profitable?

Do institutionals & insiders believe in TMCI or BVS?

Do analysts rate TMCI or BVS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMCI vs. The Competition

Treace Medical Concepts Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools